lncRNA

Xianrong Lin, Yuxin Wu, Qi Wu, Wenjun Tao, Jun Zhang, Jun Zhou

Abstract read

In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xianrong LinState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.

Yuxin WuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.

Qi WuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.

Wenjun TaoState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.ORCID 0009-0009-6120-5900

Jun ZhangState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0001-7692-9105

Jun ZhouState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0001-7261-2207

Funding

Fundamental Research Funds for the Central Universities 2632025TD05National Key Research and Development Program of China 2023YFC2706303National Natural Science Foundation of China 82173053National Natural Science Foundation of China 92581126

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cisplatin resistanceNAS1NF-κB signalingNR2F1TGFB1

Identifiers

PMID41976381

DOI10.3390/cancers18071159

PMCPMC13072194

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.